Fidelity Healthy Future Fund (FAPHX) is an actively managed open-end mutual fund offered by Fidelity Investments that primarily seeks long-term growth of capital by investing at least 80% of its assets in equity securities of companies engaged in activities to extend or improve human life expectancy, enhance health and wellness, and mitigate environmental impacts on health and wellness. The fund targets global companies across sectors such as healthcare, biotechnology, pharmaceuticals, medical devices, health technology, wellness products, and sustainable environmental solutions, incorporating Fidelity's proprietary ESG ratings framework alongside third-party ESG data to evaluate sustainable business practices; it maintains a diversified portfolio with a turnover rate of 48% and net assets of approximately $8.08 million as of late 2025. Fidelity Investments, founded in 1946 and headquartered in Boston, Massachusetts, serves as the investment manager, with the fund operating primarily in the United States market while holding international equities.
Launched in 2021 as part of Fidelity's expansion into ESG-focused strategies, the fund was introduced to capture investor interest in health innovation and sustainability themes amid growing demand for thematic equity investments. Recent portfolio updates as of 2025 reflect ongoing active management with a 12-month NAV range of $11.56 to $14.24 and emphasis on large-cap growth stocks in the Morningstar Large Growth category. No major acquisitions, funding rounds, partnerships, or strategic reorganizations have been reported for the fund in the last 1-2 years, maintaining its core focus without significant operational shifts.